Is BB Biotech AG stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, BB Biotech AG pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Monday 25th of March 2024 were paid CHF2 per share. Over the last 20 times between 2004 and 2024, BB Biotech AG has paid CHF80.7 with an average of CHF4.04 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for BB Biotech AG 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was CHF61.85, you would have made a loss of CHF-25.00 per share or -40.42%
Yes, the average daily trading liquidity for BB Biotech AG is CHF58 680 thousand. You should therefore be able to get in and out of your positions relatively fast.
BB Biotech AG has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.13, the company's ability to pay off the debt is normal. BB Biotech AG has a very good net profit margin of 93.81% and should have very high tolerances against inflation.
We have calculated the inflation risk for BB Biotech AG to be low [0.3 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.